Fabricant chinois de poudre de stéroïdes anabolisants
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнськаудмурт кыл

Anesthésiques locaux

» Médicaments » Anesthésiques locaux

  • Caractéristiques
  • Description du produit
  • Utilisation du produit
  • certificat d'authenticité

Chemical name: Bupivacaine
MF: C18H28N2O
MW: 288.43
CAS: 2180-92-9
Apparence: poudre blanche
Pureté: plus de 99%

Bupivacaine is only found in individuals that have used or taken this drug. It is a widely used local anesthetic agent. [PubChem]Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Bupivacaine binds to the intracellular portion of sodium channels and blocks sodium influx into nerve cells, which prevents depolarization. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: pain, temperature, touch, proprioception, and skeletal muscle tone. The analgesic effects of Bupivicaine are thought to potentially be due to its binding to the prostaglandin E2 receptors, subtype EP1 (PGE2EP1), which inhibits the production of prostaglandins, thereby reducing fever, inflammation, and hyperalgesia.

Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action. The 0.75% (most concentrated) formulation is used in retrobulbar block. It is the most commonly used local anesthetic in epidural anesthesia during labor, as well as in postoperative pain management.Liposomal formulations of buipivacaine are no more effective than plain solutions of bupivacaine.

Bupivacaine is contraindicated in patients with known hypersensitivity reactions to bupivacaine or amino-amide anesthetics. It is also contraindicated in obstetrical paracervical blocks and intravenous regional anaesthesia (Bier block) because of potential risk of tourniquet failure and systemic absorption of the drug and subsequent cardiac arrest. The 0.75% formulation is contraindicated in epidural anesthesia during labor because of the association with refractory cardiac arrest.

Items of analysis spécification Résultats
Apparence White or off white crystalline powder Conforme
Solubilité reely soluble in Dichloromethane, soluble dans l'éthanol, and Ethyl acetate, insoluble dans l'eau. Conforme
IdentifIcation ET ;The retention time of the major peak in the choramtogram of the Assay preparation corresponds to that in the Conforme
Point de fusion 106℃~110℃ 106.6℃~109.2℃
Perte au séchage ≤ 0.5% 0.03%
any individual impurity not more than 0.3% 0.05%
total impurities not more than 0.5% 0.06%
Limit of residual solvents Conform to standard Conforme
Résidu à l'allumage ≤0.1% 0.03%
Essai ≥98.5% 99.67%
Conclusion Qualified

formulaire ( nous vous répondrons dans les plus brefs délais )

Nom:
*
E-mail:
*
Message:

Vérification:
1 + 4 = ?

Peut-être que vous aimez aussi

  • Notre avantage

    Bon prix

    Haute qualité

    Livraison rapide

    Expédition sécurisée

    Excellent service après-vente

  • Entrepôt local

    Entrepôt UE

    Entrepôt au Royaume-Uni

    Entrepôt aux États-Unis

    Canada Entrepôt

    Australie Entrepôt

  • Mode de paiement

    Pay Pal

    Bitcoin

    Virement bancaire

    Gramme d'argent

    Western union

  • Nous contacter

    E-mail: jacob@steroid-peptide.com

    Whatsapp: +8615636286252

    Téléphoner: 0086-15636286252

    Site Internet: www.steroid-peptide.com

    Bienvenue votre enquête